[Immunomodulating therapy of middle-aged and elderly patients with erysipelas].
D000276:Adjuvants, Immunologic / Q000627:therapeutic use*; D000368:Aged; D000369:Aged, 80 and over; D004341:Drug Evaluation; D004359:Drug Therapy, Combination; D004886:Erysipelas / Q000188:drug therapy*; D005260:Female; D006801:Humans; D007978:Levamisole / Q000627:therapeutic use; D008297:Male; D008875:Middle Aged; D009696:Nucleic Acids / Q000627:therapeutic use; D012331:RNA, Fungal / Q000627:therapeutic use; D014498:Uracil / Q000031:analogs & derivatives / Q000627:therapeutic use
D000276:Adjuvants, Immunologic; D009696:Nucleic Acids; D012331:RNA, Fungal; D007978:Levamisole; D014498:Uracil; C008378:6-methyluracil; C013683:sodium nucleinate
Immunomoduliruiushchaia terapiia bol'nykh rozheĭ v pozhilom i starcheskom vozraste.